Compare BridgeBio Pharma Inc (BBIO) vs Invesco S&P 500 Low Volatility ETF (SPLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Invesco S&P 500 Low Volatility ETF — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Invesco S&P 500 Low Volatility ETF trades at $75.93. Which is the better fit depends on your goals.
| BBIO | SPLV | |
|---|---|---|
Market Cap | $16.27B | — |
Sector | Health | — |
52-Week High | $90.17 | $77.45 |
52-Week Low | $44.81 | $70.30 |
Enterprise Value | $17.82B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Invesco S&P 500 Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the "index Provider") compiles, maintains and calculates the underlying index, which is designed to measure the performance of the 100 least volatile constituents of the S&P 500 ® Index over the past 12 months as determined by the index Provider.
Read more on SPLV →
